Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer
- 1 May 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (2) , 305-310
- https://doi.org/10.1006/gyno.2002.6620
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer PatientsJournal of Clinical Oncology, 2002
- INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVOJournal of Urology, 2000
- Is cyclooxygenase-2 the alpha and the omega in cancer?Journal of Clinical Investigation, 2000
- High Cyclooxygenase-2 Expression in Stage IB Cervical Cancer with Lymph Node Metastasis or Parametrial InvasionGynecologic Oncology, 2000
- Regulation of Cyclooxygenase-2 pathway by HER2 receptorOncogene, 1999
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996
- Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.Journal of Clinical Investigation, 1994
- Overexpression of the Oncogene c-erb B2 in Primary Ovarian CancerInternational Journal of Gynecological Pathology, 1994
- Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958